National HealthCare Corp.

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: US6359061008
USD
136.59
-1.09 (-0.79%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About National HealthCare Corp. stock-summary
stock-summary
National HealthCare Corp.
Hospital
National HealthCare Corporation (NHC) is engaged in the operation of skilled nursing facilities, assisted living facilities, independent living facilities and homecare programs. The Company is engaged in the post-acute healthcare industry segment. Its business activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home healthcare services. It has interest in a hospice care business that services NHC owned healthcare centers and others. In addition, it provides management services, accounting and financial services, as well as insurance services to third-party operators of healthcare facilities. As of December 31, 2016, it owned the real estate of 13 healthcare properties and leased these properties to third-party operators. As of December 31, 2016, it operated in 10 states, and its owned and leased properties are located in various parts of the United States.
Company Coordinates stock-summary
Company Details
100 E Vine St , MURFREESBORO TN : 37130-3734
stock-summary
Tel: 1 615 8902020
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 57 Schemes (35.91%)

Foreign Institutions

Held by 77 Foreign Institutions (3.8%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Robert Adams
Non-Executive Chairman of the Board
Dr. Stephen Flatt
Chief Executive Officer, Director
Mr. W. Andrew Adams
Director
Dr. J. Paul Abernathy
Independent Director
Mr. Ernest Burgess
Independent Director
Mr. Emil Hassan
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
373 Million
(Quarterly Results - Jun 2025)
Net Profit:
24 Million
stock-summary
Industry

Hospital

stock-summary
Market cap

USD 1,797 Million (Small Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

105.09%

stock-summary
Debt Equity

-0.30

stock-summary
Return on Equity

9.50%

stock-summary
Price to Book

1.76